Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OPCH
BuyUnloved QualityFLAGOption Care Health, Inc. · Healthcare · United States · $3.6B · Avg Vol: $47M/d
Insufficient evidence for a screen-pass. Option Care Health, Inc.: fails the quant gate on momentum (Q59/V59/M41; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
COMPANY DESCRIPTION
Option Care Health, Inc. is a leading national provider of comprehensive home and alternate site infusion services for patients with complex and chronic conditions across the United States. The company's competitive moat is its extensive national network of pharmacies and nursing services, combined with deep clinical expertise in managing specialized infusion therapies. This cost-effective and patient-centric care model positions Option Care Health advantageously within the evolving healthcare landscape.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.9B | 4.3B | 5.0B | 5.6B | 12.7% | 5.7B | 5.8B | 6.1B | 4.2% |
| EPS | 0.83 | 1.49 | 1.23 | 1.28 | 15.5% | 1.32 | 1.40 | 1.55 | 10.0% |
| Shares | 182.0M | 174.6M | 166.3M | 156.9M | -13.8% | 149.8M | — | — | — |
| Debt | 1.2B | 1.2B | 1.2B | 1.3B | 3.3% | 1.3B | — | — | — |
| Equity | 1.4B | 1.4B | 1.4B | 1.3B | -1.5% | — | — | — | — |
| Op CF | 267.5M | 371.3M | 323.4M | 258.4M | -1.1% | 346.8M | — | — | — |
| Inv CF | -108.1M | -56.5M | -36.5M | -161.1M | — | — | — | — | — |
| Fin CF | 15.3M | -265.1M | -218.2M | -277.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OPCH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OPCH | Option Care Health, Inc.(you) | $3.6B | 68 | Buy |
| ACHC | Acadia Healthcare Company, Inc. | $2.7B | 57 | Hold |
| LFST | LifeStance Health Group, Inc. | $4.7B | 80 | Buy |
| PACS | PACS Group, Inc. | $6.8B | 74 | Buy |
| INNV | InnovAge Holding Corp. | $1.5B | 63 | Hold |
| SGRY | Surgery Partners, Inc. | $1.8B | 58 | Hold |
| NHC | National HealthCare Corporation | $3.5B | 92 | Strong Buy |
| PNTG | The Pennant Group, Inc. | $1.3B | 64 | Hold |
| ASTH | Astrana Health, Inc. | $1.9B | 83 | Strong Buy |
| USPH | U.S. Physical Therapy, Inc. | $1.2B | 62 | Hold |
Peer medians: ROE -30.2% · P/E 27.1x · Gross margin 58.3%